ATUM

Trending Articles

  1. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the...
  2. dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient
  3. Roche's cancer immunotherapy Tecentriq Hybreza bags FDA approval The drug first and only subcutaneous PD-(L)1 inhibitor available for patients with certain types of lung, skin, liver and soft tissue cancers
  4. Moderna's mRNA manufacturing facility bags Canadian Drug Establishment License The Canadian facility can now domestically manufacture a range of mRNA vaccines to treat respiratory viruses
  5. Genesis Pharma to distribute Santhera's Agamree for DMD The therapeutic recently received EC approval to treat patients over 4 years old with Duchenne muscular dystrophy

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Manufacturing

Rentschler and ATUM announce Leap-In Transposase agreement

Rentschler and ATUM have announced the signing of a CDMO licensing agreement for the Leap-In Transposase platform
Research & Development

ATUM licenses gene design software to Thermo Fisher Scientific

Patented Gene Designer 2.0 software speeds discovery with visually rich graphical interface
Research & Development

ATUM launches cell-line development service

Expansion is supported by four broad patents for company’s Leap-In Transposase technology
Research & Development

DNA2.0 Becomes ATUM

Founded in 2003 to marry computational design and gene synthesis, DNA2.0 was a pioneer in the application of machine learning (or artificial intelligence) to biology
Subscribe now